NAMCP Medical Directors Institute’s
“Value Based Care Council”
Executive Director: Michael A. Ford, RPh
(click on the company name to visit their website)
Boston Scientific – Advancing Science For Life
Coherus Biosciences – Choice Without Compromise
CSL Behring – Biotherapies for Life
Genentech – A member of the Roche Group
Gilead – Creating Possible
Hologic – Breakthrough Diagnostic and Medical Imaging Solutions
Karuna, Pushing the Boundaries of Neuroscience to
Transform the Treatment of Mental Illness
Leo Pharma – Dermatology Beyond the Skin
Lucid Diagnostics, Advancing Possible
Medtronic, Technology Worthy of the Human Body
Merck – Inventing For Life
Mitsubishi Tanabe Pharma America
Novartis – Reimagining Medicine
Otsuka – Welcome to Otsuka in the U.S.
Sandoz – A Novartis Division
Scipher Medicine – Solving America’s Large Drug Problem
Seagen – Dedicated to Revolutionizing Cancer Care
Takeda – Better Health, Brighter Future
Teva Pharma – Committed to Improving the Lives of Patients
The Kinetix Group
Verrica Pharmaceuticals – Reinventing Skin Science
NAMCP understands the changing landscape with regard to the delivery of healthcare is moving from traditional fee for service to more of a focus on value based care and all of the complexities therein. In that pharmaceuticals are the mainstay of the treatment plan or therapy for most medical conditions, the association made the decision to move forward with an initiative to work with Medical Directors and other stakeholders to improve medical outcomes through the more effective utilization of pharmaceuticals.
“We believe the work you’re doing is important and
are excited to continue collaborating.”
Steven Pray – Director, Channel Marketing
Novartis Pharmaceuticals Corporation, US Oncology
The council works with Medical Directors to develop solutions, including, but not limited to standardized tools and resources to assist in the more effective extraction of pharmaceutical value so as to optimize medical outcomes.
Triple AIM Goals
The council is dedicated to assisting Medical Directors with the achievement of the Triple AIM goals of improved outcomes, improved patient satisfaction, and reduction of medical costs.
The focus of the council will be on pharmaceutical value, adherence and persistency, strategies and methodologies to effectively leverage value of pharmacy spend, and the critical components of pharmaceutical value based contracts. In addition, the council will explore and discuss other value based care landscape issues and develop projects such as analytical studies and white papers that drive better informed policy, coverage and healthcare delivery.
Tools and Resources
In response to a agreed upon unmet need in the marketplace, the Value Based Care Council developed a short form in order to enhance the effectiveness and efficiency with which product value propositions can be shared between industry and the medical leadership of various payers throughout the country. This same short form provides a concise and consistent manner with which product value propositions can be shared while also providing the ability to align expectations prior to actually conducting conversations or having a meeting regarding a product or service.
This form is to be utilized by the customer as an unsolicited request to industry. It contains guidance for industry as it pertains to the customer, as well as the form allows for a response to be a maximum of 3 pages.
For more information, please contact NAMCP at 804-527-1905 or email email@example.com